Role of Nepafenac in Reducing Macular Volume After Epiretinal Membrane Surgery
NCT00818844
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Epiretinal Membrane
Interventions
DRUG:
Nepafenac 0.1%
OTHER:
BSS
Sponsor
Alcon Research